Christine Dolan - 31 Oct 2023 Form 4 Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Role
Chief Operating Officer, Biologics Safety Testing
Signature
/s/ Kurt Oreshack, by power of attorney for Christine Dolan
Issuer symbol
MRVI
Transactions as of
31 Oct 2023
Net transactions value
+$10,080
Form type
4
Filing time
16 Nov 2023, 17:21:49 UTC
Previous filing
19 Jul 2023
Next filing
18 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVI Class A Common Stock Award $10,080 +1,729 +2.3% $5.83 75,727 31 Oct 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,729 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

Remarks:

Chief Operating Officer, Biologics Safety Testing